Histone deacetylases and their role in motor neuron degeneration

Frontiers in Cellular Neuroscience

Volumn 7, Issue DEC, 2013, Pages

  Lazo Gómez, Rafael ^a   Ramírez Jarquín, Uri N ^a   Tovar y Romo, Luis B ^a   Tapia, Ricardo ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Amyotrophic lateral sclerosis; Histone deacetylases; Neurodegeneration; Neuroprotection; Sirtuins; Transcription dysregulation

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HISTONE DEACETYLASE; HISTONE DEACETYLASE 3; SIRTUIN; SIRTUIN 2;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; GENE EXPRESSION; HISTONE ACETYLATION; HUMAN; IN SITU HYBRIDIZATION; MOTONEURON; NERVE DEGENERATION; PROTEIN EXPRESSION; UPREGULATION;

EID: 84889575565     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00243     Document Type: Article

References (62)

1. Barthélémy, C., Henderson, C. E., and Pettmann, B. (2004). Foxo3a induces motoneuron death through the Fas pathway in cooperation with JNK. BMC Neurosci.5:48. doi: 10.1186/1471-2202-5-48
2. Bhaumik, S. R., Smith, E., and Shilatifard, A. (2007). Covalent modifications of histones during development and disease pathogenesis. Nat. Struct. Mol. Biol. 14, 1008-1016. doi: 10.1038/nsmb1337
3. Broide, R. S., Redwine, J. M., Aftahi, N., Young, W., Bloom, F. E., and Winrow, C. J. (2007). Distribution of histone deacetylases 1-11 in the rat brain. J. Mol. Neurosci.31, 47-58. doi: 10.1007/bf02686117
4. Cantó, C., and Auwerx, J. (2009). PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol. 20, 98-105. doi: 10.1097/mol.0b013e328328d0a4
5. Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., et al. (2009). AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056-1060. doi: 10.1038/nature07813
6. Cha, J. H. (2000). Transcriptional dysregulation in Huntington's disease. Trends Neurosci. 23, 387-392. doi: 10.1016/s0166-2236(00)01609-x
7. Chen, Y. T., Zang, X. F., Pan, J., Zhu, X. L., Chen, F., Chen, Z. B., et al. (2012). Expression patterns of histone deacetylases in experimental stroke and potential targets for neuroprotection. Clin. Exp. Pharmacol. Physiol. 39, 751-758. doi: 10.1111/j.1440-1681.2012.05729.x
8. Corcoran, L. J., Mitchison, T. J., and Liu, Q. (2004). A novel action of histone deacetylase inhibitors in a protein aggresome disease model. Curr. Biol. 14, 488-492. doi: 10.1016/j.cub.2004.03.003
9. Corona, J. C., Tovar-y-Romo, L. B., and Tapia, R. (2007). Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis. Expert Opin. Ther. Targets11, 1415-14128. doi: 10.1517/14728222.11.11.1415
10. Cudkowicz, M. E., Andres, P. L., Macdonald, S. A., Bedlack, R. S., Choudry, R., Brown, R. H., et al. (2009). Phase 2 study of sodium phenylbutyrate in ALS. Amyotroph. Lateral Scler. 10, 99-106. doi: 10.1080/17482960802320487
11. Dasgupta, B., and Milbrandt, J. (2007). Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl. Acad. Sci. U S A 104, 7217-7222. doi: 10.1073/pnas.0610068104
12. de Ruijter, A. J., van Gennip, A. H., Caron, H. N., Kemp, S., and van Kuilenburg, A. B. (2003). Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370, 737-749. doi: 10.1042/bj20021321
13. Del Signore, S. J., Amante, D. J., Kim, J., Stack, E. C., Goodrich, S., Cormier, K., et al. (2009). Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice. Amyotroph. Lateral Scler. 10, 85-94. doi: 10.1080/17482960802226148
14. Eijkelenboom, A., and Burgering, B. M. (2013). FOXOs: signalling integrators for homeostasis maintenance. Nat. Rev. Mol. Cell Biol. 14, 83-97. doi: 10.1038/nrm3507
15. Figueroa-Romero, C., Hur, J., Bender, D. E., Delaney, C. E., Cataldo, M. D., Smith, A. L., et al. (2012). Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis. PLoS One 7:e52672. doi: 10.1371/journal.pone.0052672
16. Frew, A. J., Johnstone, R. W., and Bolden, J. E. (2009). Enhancing the apoptotic and therapeutic effects of HDAC inhibitors. Cancer Lett. 280, 125-133. doi: 10.1016/j.canlet.2009.02.042
17. Haigis, M. C., and Sinclair, D. A. (2010). Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 5, 253-295. doi: 10.1146/annurev.pathol.4.110807.092250
18. Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., et al. (2002). HDAC6 is a microtubule-associated deacetylase. Nature 417, 455-458. doi: 10.1038/417455a
19. Imai, S., Armstrong, C. M., Kaeberlein, M., and Guarente, L. (2000). Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature403, 795-800. doi: 10.1038/35001622
20. Janssen, C., Schmalbach, S., Boeselt, S., Sarlette, A., Dengler, R., and Petri, S. (2010). Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 69, 573-581. doi: 10.1097/nen.0b013e3181ddd404
21. Jiang, M., Wang, J., Fu, J., Du, L., Jeong, H., West, T., et al. (2012). Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets. Nat. Med. 18, 153-158. doi: 10.1038/nm.2558
22. Kaeberlein, M., McVey, M., and Guarente, L. (1999). The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13, 2570-2580. doi: 10.1101/gad.13.19.2570
23. Kanai, H., Sawa, A., Chen, R. W., Leeds, P., and Chuang, D. M. (2004). Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons. Pharmacogenomics J. 4, 336-344. doi: 10.1038/sj.tpj.6500269
24. Kazantsev, A. G., and Thompson, L. M. (2008). Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat. Rev. Drug Discov. 7, 854-868. doi: 10.1038/nrd2681
25. Kernochan, L. E., Russo, M. L., Woodling, N. S., Huynh, T. N., Avila, A. M., Fischbeck, K. H., et al. (2005). The role of histone acetylation in SMN gene expression. Hum. Mol. Genet. 14, 1171-1182. doi: 10.1093/hmg/ddi130
26. Kim, D., Nguyen, M. D., Dobbin, M. M., Fischer, A., Sananbenesi, F., Rodgers, J. T., et al. (2007). SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 26, 3169-3179. doi: 10.1038/sj.emboj.7601758
27. Kim, S. H., Shanware, N. P., Bowler, M. J., and Tibbetts, R. S. (2010). Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA. J. Biol. Chem. 285, 34097-34105. doi: 10.1074/jbc.m110.154831
28. Kirby, J., Halligan, E., Baptista, M. J., Allen, S., Heath, P. R., Holden, H., et al. (2005). Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS. Brain 128, 1686-1706. doi: 10.1093/brain/awh503
29. Kouzarides, T. (2007). Chromatin modifications and their function. Cell 128, 693-705. doi: 10.1016/j.cell.2007.02.005
30. Lee, J. C., Shin, J. H., Park, B. W., Kim, G. S., Kim, J. C., Kang, K. S., et al. (2012). Region-specific changes in the immunoreactivity of SIRT1 expression in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis. Brain Res. 1433, 20-28. doi: 10.1016/j.brainres.2011.11.019
31. Li, X. (2013). SIRT1 and energy metabolism. Acta Biochim. Biophys. Sin. (Shanghai)45, 51-60. doi: 10.1093/abbs/gms108
32. Liang, H., Ward, W. F., Jang, Y. C., Bhattacharya, A., Bokov, A. F., Li, Y., et al. (2011). PGC-1alpha protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse model. Muscle Nerve 44, 947-956. doi: 10.1002/mus.22217
33. + consumption by SIRT1 may endanger energetically compromised neurons. Neuromolecular Med. 11, 28-42. doi: 10.1007/s12017-009-8058-1
34. Liu, H., Hu, Q., D'Ercole A, J., and Ye, P. (2009b). Histone deacetylase 11 regulates oligodendrocyte-specific gene expression and cell development in OL-1 oligodendroglia cells. Glia 57, 1-12. doi: 10.1002/glia.20729
35. Liu, H., Hu, Q., Kaufman, A., D'Ercole, A. J., and Ye, P. (2008). Developmental expression of histone deacetylase 11 in the murine brain. J. Neurosci. Res. 86, 537-543. doi: 10.1002/jnr.21521
36. Michan, S., and Sinclair, D. (2007). Sirtuins in mammals: insights into their biological function. Biochem. J. 404, 1-13. doi: 10.1042/bj20070140
37. Mojsilovic-Petrovic, J., Nedelsky, N., Boccitto, M., Mano, I., Georgiades, S. N., Zhou, W., et al. (2009). FOXO3a is broadly neuroprotective in vitro and in vivo against insults implicated in motor neuron diseases. J. Neurosci. 29, 8236-8247. doi: 10.1523/jneurosci.1805-09.2009
38. Monti, B., Polazzi, E., and Contestabile, A. (2009). Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr. Mol. Pharmacol. 2, 95-109. doi: 10.2174/1874-470210902010095
39. Pandey, U. B., Nie, Z., Batlevi, Y., McCray, B. A., Ritson, G. P., Nedelsky, N. B., et al. (2007). HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447, 859-863. doi: 10.1038/nature05853
40. Petri, S., Kiaei, M., Kipiani, K., Chen, J., Calingasan, N. Y., Crow, J. P., et al. (2006). Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 22, 40-49. doi: 10.1016/j.nbd.2005.09.013
41. Piepers, S., Veldink, J. H., de Jong, S. W., van der Tweel, I., van der Pol, W. L., Uijtendaal, E. V., et al. (2009). Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis. Ann. Neurol. 66, 227-234. doi: 10.1002/ana.21620
42. Robakis, N. K. (2003). An Alzheimer's disease hypothesis based on transcriptional dysregulation. Amyloid 10, 80-85. doi: 10.3109/13506120309041729
43. Robberecht, W., and Philips, T. (2013). The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 14, 248-264. doi: 10.1038/nrn3430
44. Rouaux, C., Panteleeva, I., Rene, F., Gonzalez de Aguilar, J. L., Echaniz-Laguna, A., Dupuis, L., et al. (2007). Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. J. Neurosci. 27, 5535-5545. doi: 10.1523/jneurosci.1139-07.2007
45. Ryu, H., Smith, K., Camelo, S. I., Carreras, I., Lee, J., Iglesias, A. H., et al. (2005). Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. J. Neurochem. 93, 1087-1098. doi: 10.1111/j.1471-4159.2005.03077.x
46. Santa-Cruz, L. D., Ramírez-Jarquín, U. N., and Tapia, R. (2012). "Role of mitochondrial dysfunction in motor neuron degeneration in ALS, " in Amyotrophic Lateral Sclerosis, ed M. H. Maurer (In Tech, Rijeka, Croatia). 197-224.
47. Selvi, B. R., Cassel, J. C., Kundu, T. K., and Boutillier, A. L. (2010). Tuning acetylation levels with HAT activators: therapeutic strategy in neurodegenerative diseases. Biochim. Biophys. Acta 1799, 840-853. doi: 10.1016/j.bbagrm.2010.08.012
48. Smith, J. S., Brachmann, C. B., Celic, I., Kenna, M. A., Muhammad, S., Starai, V. J., et al. (2000). A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. Proc. Natl. Acad. Sci. U S A 97, 6658-6663. doi: 10.1073/pnas.97.12.6658
49. Song, W., Song, Y., Kincaid, B., Bossy, B., and Bossy-Wetzel, E. (2013). Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1alpha. Neurobiol. Dis. 51, 72-81. doi: 10.1016/j.nbd.2012.07.004
50. Tang, B. L. (2010). Resveratrol is neuroprotective because it is not a direct activator of Sirt1-A hypothesis. Brain Res. Bull. 81, 359-361. doi: 10.1016/j.brainresbull.2009.12.007
51. Tanno, M., Sakamoto, J., Miura, T., Shimamoto, K., and Horio, Y. (2007). Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J. Biol. Chem. 282, 6823-6832. doi: 10.1074/jbc.m609554200
52. Thau, N., Knippenberg, S., Korner, S., Rath, K. J., Dengler, R., and Petri, S. (2012). Decreased mRNA expression of PGC-1alpha and PGC-1alpha-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS. J. Neuropathol. Exp. Neurol. 71, 1064-1074. doi: 10.1097/nen.0b013e318275df4b
53. Todd, P. K., Oh, S. Y., Krans, A., Pandey, U. B., Di Prospero, N. A., Min, K. T., et al. (2010). Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome. PLoS Genet.6:e1001240. doi: 10.1371/journal.pgen.1001240
54. Tovar-y-Romo, L. B., Zepeda, A., and Tapia, R. (2007). Vascular endothelial growth factor prevents paralysis and motoneuron death in a rat model of excitotoxic spinal cord neurodegeneration. J. Neuropathol. Exp. Neurol. 66, 913-922. doi: 10.1097/nen.0b013e3181567c16
55. Wang, J., Zhang, Y., Tang, L., Zhang, N., and Fan, D. (2011). Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis. Neurosci. Lett. 503, 250-255. doi: 10.1016/j.neulet.2011.08.047
56. Yacoubian, T. A., Cantuti-Castelvetri, I., Bouzou, B., Asteris, G., McLean, P. J., Hyman, B. T., et al. (2008). Transcriptional dysregulation in a transgenic model of Parkinson disease. Neurobiol. Dis. 29, 515-528. doi: 10.1016/j.nbd.2007.11.008
57. Yao, Z. G., Zhang, L., Huang, L., Zhu, H., Liu, Y., Ma, C. M., et al. (2013). Regional and cell-type specific distribution of HDAC2 in the adult mouse brain. Brain Struct. Funct.218, 563-573. doi: 10.1007/s00429-012-0416-3
58. Yoo, Y. E., and Ko, C. P. (2011). Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 231, 147-159. doi: 10.1016/j.expneurol.2011.06.003
59. Zakhary, S. M., Ayubcha, D., Dileo, J. N., Jose, R., Leheste, J. R., Horowitz, J. M., et al. (2010). Distribution analysis of deacetylase SIRT1 in rodent and human nervous systems. Anat. Rec. (Hoboken) 293, 1024-1032. doi: 10.1002/ar.21116
60. Zhao, W., Varghese, M., Yemul, S., Pan, Y., Cheng, A., Marano, P., et al. (2011a). Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1alpha) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis. Mol. Neurodegener. 6:51. doi: 10.1186/1750-1326-6-51
61. Zhao, Y., Wang, Y., and Zhu, W. G. (2011b). Applications of post-translational modifications of FoxO family proteins in biological functions. J. Mol. Cell Biol. 3, 276-282. doi: 10.1093/jmcb/mjr013
62. Zhou, V. W., Goren, A., and Bernstein, B. E. (2011). Charting histone modifications and the functional organization of mammalian genomes. Nat. Rev. Genet. 12, 7-18. doi: 10.1038/nrg2905